174 related articles for article (PubMed ID: 16361289)
1. The association between polycystic ovaries and endometrial cancer.
Pillay OC; Te Fong LF; Crow JC; Benjamin E; Mould T; Atiomo W; Menon PA; Leonard AJ; Hardiman P
Hum Reprod; 2006 Apr; 21(4):924-9. PubMed ID: 16361289
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome and endometrial cancer.
Navaratnarajah R; Pillay OC; Hardiman P
Semin Reprod Med; 2008 Jan; 26(1):62-71. PubMed ID: 18181084
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
4. Endometrial adenocarcinoma and polycystic ovary syndrome: risk factors, management, and prognosis.
Elliott JL; Hosford SL; Demopoulos RI; Perloe M; Sills ES
South Med J; 2001 May; 94(5):529-31. PubMed ID: 11372809
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
6. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
Engin-Ustün Y; Ustün Y; Meydanli MM; Kafkasli A; Yetkin G
Gynecol Endocrinol; 2006 Jun; 22(6):324-8. PubMed ID: 16785157
[TBL] [Abstract][Full Text] [Related]
7. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
8. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
Sahu B; Ozturk O; Ranierri M; Serhal P
Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140
[TBL] [Abstract][Full Text] [Related]
9. Premalignant lesions in the contralateral ovary of women with unilateral ovarian carcinoma.
Kaur TB; Shen T; Gaughan J; Thompson J; Houck KL; Richardson M; Hernandez E
Gynecol Oncol; 2004 Apr; 93(1):69-77. PubMed ID: 15047216
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.
Fearnley EJ; Marquart L; Spurdle AB; Weinstein P; Webb PM;
Cancer Causes Control; 2010 Dec; 21(12):2303-8. PubMed ID: 20953904
[TBL] [Abstract][Full Text] [Related]
11. Significance of cyclin D1 expression in meningiomas: a preliminary study.
Alama A; Barbieri F; Spaziante R; Bruzzo C; Dadati P; Dorcaratto A; Ravetti JL
J Clin Neurosci; 2007 Apr; 14(4):355-8. PubMed ID: 17240151
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
[TBL] [Abstract][Full Text] [Related]
13. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
14. [Endometrial carcinoma with polycystic ovaries. Report of two cases in women younger than 40 years old].
Gregorini SD; Lespi PJ; Alvarez GR
Medicina (B Aires); 1997; 57(2):209-12. PubMed ID: 9532832
[TBL] [Abstract][Full Text] [Related]
15. [Incidence of fibrocystic disease of the breast in women with polycystic ovary. Clinico-instrumental study].
D'Amelio R; Farris M; Grande S; Feraudo E; Iuliano A
Minerva Ginecol; 2000 Sep; 52(9):321-5. PubMed ID: 11189960
[TBL] [Abstract][Full Text] [Related]
16. The role of androst-5-ene-3β,17β-diol (androstenediol) in cell proliferation in endometrium of women with polycystic ovary syndrome.
Plaza-Parrochia F; Bacallao K; Poblete C; Gabler F; Carvajal R; Romero C; Valladares L; Vega M
Steroids; 2014 Nov; 89():11-9. PubMed ID: 25065586
[TBL] [Abstract][Full Text] [Related]
17. p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium.
Horn LC; Richter CE; Einenkel J; Tannapfel A; Liebert UG; Leo C
Ann Diagn Pathol; 2006 Aug; 10(4):193-6. PubMed ID: 16844559
[TBL] [Abstract][Full Text] [Related]
18. Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): time for paradigm shift?
Shafiee MN; Chapman C; Barrett D; Abu J; Atiomo W
Gynecol Oncol; 2013 Nov; 131(2):489-92. PubMed ID: 23822891
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
20. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
Aoyagi S; Akiyama M; Shimizu H
J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]